A potential wound healing-promoting peptide from frog skin

Area of Science:

• Biochemistry
• Dermatology
• Pharmacology

Background:

• Cutaneous wound healing is complex, involving multiple cell types and processes.
• Transforming growth factor beta 1 (TGF-β1) is crucial for effective wound repair.
• Amphibian skin exhibits remarkable healing capabilities, yet specific bioactive factors remain largely unidentified.

Purpose of the Study:

• To identify and characterize a novel bioactive peptide from amphibian skin with wound healing potential.
• To elucidate the underlying molecular mechanisms by which this peptide promotes cutaneous wound repair.

Main Methods:

• Identification of peptide AH90 from Odorrana grahami frog skin.
• Assessment of AH90's wound healing activity in a murine full-thickness dermal wound model.
• Investigation of signaling pathways involved: nuclear factor-κB (NF-κB), c-Jun NH2-terminal kinase (JNK), and Smads proteins.

Main Results:

• Peptide AH90 demonstrated significant wound healing promotion in vivo.
• AH90 induced TGF-β1 release by activating NF-κB and JNK signaling pathways.
• The peptide's effects on Smads proteins were mediated by TGF-β1, as confirmed by antibody inhibition.

Conclusions:

• AH90 promotes cutaneous wound healing by stimulating endogenous TGF-β1 production through NF-κB and JNK activation.
• This study reveals a novel mechanism for amphibian-derived peptides in wound repair.
• AH90 serves as a potential template for developing new wound healing agents due to its efficacy and lack of mitogenic effects.